Australia issues new medical device guidance document:
This article was originally published in Clinica
Executive Summary
The Australian Therapeutic Goods Administration (TGA) has issued a guidance document, which is part of a series aimed at explaining the new regulatory system for medical devices in Australia, introduced in October 2002. The document outlines the obligations and responsibilities of sponsors and manufacturers of medical devices after they have been approved for distribution nationally. Manufacturers must maintain technical documentation that demonstrates that their products conform to the essential principles of quality, safety and performance. They must further provide evidence that the appropriate conformity assessment procedure has been applied. This data must be made available upon request by the TGA. In addition, sponsors must have access to this evidence and be able to provide it on request. The document can be downloaded at: http://www.health.gov.au/tga/docs/pdf/devguid11.pdf
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.